NDA 16813, held by Fisons. Isoproterenol Hydrochloride.
As of Nov 14, 2026, NDA 16813 (Vapo-Iso), held by Fisons, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Vapo-Iso0.5% ยท solution;inhalation | Isoproterenol Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
